Literature DB >> 25908718

Development of Red Flags Index for Early Referral of Adults with Symptoms and Signs Suggestive of Crohn's Disease: An IOIBD Initiative.

Silvio Danese1, Gionata Fiorino2, Jean-Yves Mary3, Peter L Lakatos4, Geert D'Haens5, Lorenzo Moja6, André D'Hoore7, Julian Panes8, Walter Reinisch9, William J Sandborn10, Simon P Travis11, Séverine Vermeire12, Laurent Peyrin-Biroulet13, Jean-Fréderic Colombel14.   

Abstract

BACKGROUND AND AIMS: Diagnostic delay is frequent in patients with Crohn's disease (CD). We developed a tool to predict early diagnosis.
METHODS: A systematic literature review and 12 CD specialists identified 'Red Flags', i.e. symptoms or signs suggestive of CD. A 21-item questionnaire was administered to 36 healthy subjects, 80 patients with irritable bowel syndrome (non-CD group) and 85 patients with recently diagnosed (<18 months) CD. Patients with CD were asked to recall symptoms and signs they experienced during the 12 months before diagnosis. Multiple logistic regression analyses selected and weighted independent items to construct the Red Flags index. A receiver operating characteristic curve was used to assess the threshold that discriminated CD from non-CD. Association with the Red Flags index relative to this threshold was expressed as the odds ratios (OR).
RESULTS: Two hundred and one subjects, CD and non-CD, answered the questionnaire. The multivariate analysis identified eight items independently associated with a diagnosis of CD. A minimum Red Flags index value of 8 was highly predictive of CD diagnosis with sensitivity and specificity bootstrap estimates of 0.94 (95% confidence interval 0.88-0.99) and 0.94 (0.90-0.97), respectively. Positive and negative likelihood ratios were 15.1 (9.3-33.6) and 0.066 (0.013-0.125), respectively. The association between CD diagnosis and a Red Flags index value of ≥8 corresponds to an OR of 290 (p < 0.0001).
CONCLUSIONS: The Red Flags index using early symptoms and signs has high predictive value for the diagnosis of CD. These results need prospective validation prior to introduction into clinical practice.
Copyright © 2015 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Crohn’s disease; Red Flags; diagnostic delay

Mesh:

Year:  2015        PMID: 25908718     DOI: 10.1093/ecco-jcc/jjv067

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  23 in total

1.  Diagnostic delay in patients with inflammatory bowel disease in Austria.

Authors:  Gottfried Novacek; Hans Peter Gröchenig; Thomas Haas; Heimo Wenzl; Pius Steiner; Robert Koch; Thomas Feichtenschlager; Gerald Eckhardt; Andreas Mayer; Andreas Kirchgatterer; Othmar Ludwiczek; Reingard Platzer; Pavol Papay; Johanna Gartner; Harry Fuchssteiner; Wolfgang Miehsler; Paul-Gerhard Peters; Gerhard Reicht; Harald Vogelsang; Clemens Dejaco; Thomas Waldhör
Journal:  Wien Klin Wochenschr       Date:  2019-02-04       Impact factor: 1.704

2.  Timely Use of Biologics in Early Crohn's Disease: The Return of "Hit Hard and Early"?

Authors:  Catherine Le Berre; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  Dig Dis Sci       Date:  2019-11       Impact factor: 3.199

3.  Diagnostic Delay in Crohn's Disease: Time for Red Flags.

Authors:  Gionata Fiorino; Silvio Danese
Journal:  Dig Dis Sci       Date:  2016-09-16       Impact factor: 3.199

4.  Diagnostic dilemma: think about anterior cutaneous nerve entrapment syndrome (ACNES) in patients with atypical abdominal pain and Crohn's disease.

Authors:  Kenneth Lam; Carolyn Vasey
Journal:  BMJ Case Rep       Date:  2018-03-28

5.  A qualitative study to explore the symptoms and impacts of Crohn's disease and to develop the Crohn's Disease Diary.

Authors:  Rebecca Williams-Hall; Claire Trennery; Kate Sully; Samantha Wratten; Anya Francis; Dale Chandler; Jessica Flynn; Megan Turner; Daniel J B Marks; Alfred Sackeyfio; Marguerite Bracher; Alex Walker; Louise Walker-Nthenda; Rob Arbuckle; Tom Keeley
Journal:  Qual Life Res       Date:  2022-09-02       Impact factor: 3.440

Review 6.  Crohn's disease.

Authors:  Giulia Roda; Siew Chien Ng; Paulo Gustavo Kotze; Marjorie Argollo; Remo Panaccione; Antonino Spinelli; Arthur Kaser; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  Nat Rev Dis Primers       Date:  2020-04-02       Impact factor: 52.329

7.  Evaluation of Gastrointestinal Patient Reported Outcomes Measurement Information System (GI-PROMIS) Symptom Scales in Subjects With Inflammatory Bowel Diseases.

Authors:  Bharati Kochar; Christopher F Martin; Michael D Kappelman; Brennan M Spiegel; Wenli Chen; Robert S Sandler; Millie D Long
Journal:  Am J Gastroenterol       Date:  2017-08-29       Impact factor: 10.864

8.  Diagnostic Delay Is Associated with a Greater Risk of Early Surgery in a French Cohort of Crohn's Disease Patients.

Authors:  Stéphane Nahon; Pierre Lahmek; Thierry Paupard; Bruno Lesgourgues; Stanislas Chaussade; Laurent Peyrin-Biroulet; Vered Abitbol
Journal:  Dig Dis Sci       Date:  2016-05-20       Impact factor: 3.199

9.  RHB-104 triple antibiotics combination in culture is bactericidal and should be effective for treatment of Crohn's disease associated with Mycobacterium paratuberculosis.

Authors:  Karel P Alcedo; Saisathya Thanigachalam; Saleh A Naser
Journal:  Gut Pathog       Date:  2016-06-14       Impact factor: 4.181

10.  Inflammatory bowel disease: Clinical screening and transition of care.

Authors:  Badr Al-Bawardy
Journal:  Saudi J Gastroenterol       Date:  2017 Jul-Aug       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.